Gontivimab

Gontivimab Suppliers list
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Email: 2853530910@QQ.com
Company Name: Wuhan Chemstan Biotechnology Co., Ltd.  
Tel: 027-65317797 15926423062
Email: 422450190@qq.com
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310 15002144251
Email: marketing@tsbiochem.com
Company Name: Biolab Reagents  
Tel: 027-65279366 18108604356
Email: products@biolabreagent.com
Company Name: Wuhan Jingkangen Biomedical Technology Co., Ltd  
Tel: 13720134139 086-15871494362 13720134139
Email: orders@jknbiochem.com
Gontivimab Basic information
Product Name:Gontivimab
Synonyms:Gontivimab;Research Grade Gontivimab (DVV02806);Research Grade Gontivimab
CAS:1257358-38-5
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Gontivimab Structure
Gontivimab Chemical Properties
Safety Information
MSDS Information
Gontivimab Usage And Synthesis
UsesGontivimab (ALX-0171; VR-465) is a poent anti-RSV prefusion F protein nanobody with a KD value of 0.113 nM. Gontivimab shows antiviral activity. Gontivimab reduces the RSV load in the nose and lung[1].
in vivo

Gontivimab (1-68 mg/kg; intranasal administration or nebulization) reduces the RSV load in the nose and lungs in rats[1].

Animal Model:Rats (RSV Tracy)[1]
Dosage:1-68 mg/kg
Administration:Intranasal administration or nebulization; once (day 2 or day 3) or twice (day 2 and day 3)
Result:Resulted in significant viral load reductions in the lungs ranging.
References[1] Detalle L, et al. Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection. Antimicrob Agents Chemother. 2015 Oct 5;60(1):6-13. DOI:10.1128/AAC.01802-15
Gontivimab Preparation Products And Raw materials
Tag:Gontivimab(1257358-38-5) Related Product Information
Lorvotuzumab Mertansine Tuvirumab Zolimomabaritox Pozelimab Pateclizumab Abelacimab Iodine (131I) Apamistamab Flanvotumab Pulocimab Osocimab